Campbell & Co Investment Adviser’s Cardiovascular Systems, Inc. CSII Stock Holding History

Campbell & Co Investment Adviser’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18,846	Closed	-$257K	–	1089
2022 Q4	$257K	Buy	+18,846	New	+$262K	0.06%	605
2022 Q3	–	Sell	-10,782	Closed	-$155K	–	993
2022 Q2	$155K	Buy	+10,782	New	+$187K	0.04%	625
2022 Q1	–	Sell	-19,100	Closed	-$359K	–	960
2021 Q4	$359K	Buy	+19,100	New	+$510K	0.12%	294
2015 Q4	–	Sell	-16,057	Closed	-$254K	–	276
2015 Q3	$254K	Sell	16,057 -16,385	-51%	-$413K	0.17%	219
2015 Q2	$858K	Buy	+32,442	New	+$1.05M	0.73%	52

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

WIC

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Campbell & Co Investment Adviser's CSII Position: Q1 2023 in Review

Campbell & Co Investment Adviser sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2023, closing a stake of 18,846 shares — an estimated $257K sold.

Campbell & Co Investment Adviser first reported a position in CSII in Q2 2015 and held it in 5 quarters. The position peaked at $858K in Q2 2015. 150 funds tracked by Wall St. Rank hold CSII as of Q1 2023.

Campbell & Co Investment Adviser reported no remaining Cardiovascular Systems, Inc. position as of Q1 2023 after selling out during the quarter.
Campbell & Co Investment Adviser sold 18,846 Cardiovascular Systems, Inc. shares in Q1 2023, an estimated $257K.
Campbell & Co Investment Adviser first reported a position in Cardiovascular Systems, Inc. in Q2 2015 and held it in 5 quarters.
Campbell & Co Investment Adviser's Cardiovascular Systems, Inc. position peaked at $858K in Q2 2015.
150 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2023.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2023, filed 11 May 2023.